We address the challenges that patients with HIV and their physicians face with the long-term use of antiretroviral agents, the aging of the HIV-infected population and HIV/HCV co-infections. Clinicians are involved in evaluating the safety and efficacy of new treatment in clinical trials. We study the incidence and risk factors for AIDS-defining and non-AIDS-defining conditions such as cancers and other chronic diseases, and patterns of general disease screening and the use of preventive measures. Studies monitor adverse events after patients start on new retrovirals and identify prognostic markers in AIDS-related lymphoma.
Developing an HIV Specific-Specific Prevention Index Using Electronic Medical Record (HIV PI)
The goals of this study are to assess in HIV-infected patients, the degree of association between successful general clinical care by HIV disease-treating providers (reflected in overall adherence to recommended general prevention and screening guidelines) and higher-quality HIV-specific care and related clinical outcome.
Principal Investigator: Chun Chao, PhD, MS
Funding Source: Agency for Healthcare Research and Quality (AHRQ)
Funding Years: 2010 - 2013